These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12047490

  • 1. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
    van Kraaij DJ, Hovestad-Witterland AH, de Metz M, Vollaard EJ.
    Br J Clin Pharmacol; 2002 Jun; 53(6):644-7. PubMed ID: 12047490
    [Abstract] [Full Text] [Related]

  • 2. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers.
    de Meijer A, Vollaard H, de Metz M, Verbruggen B, Thomas C, Novakova I.
    Clin Pharmacol Ther; 1999 Oct; 66(4):425-30. PubMed ID: 10546927
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR, Renda G, Sciulli MG, Santini G, Di Giamberardino M, Rotondo MT, Tacconelli S, Seta F, Patrono C, Patrignani P.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [Abstract] [Full Text] [Related]

  • 4. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
    Stichtenoth DO, Wagner B, Frölich JC.
    J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
    [Abstract] [Full Text] [Related]

  • 5. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial.
    Rinder HM, Tracey JB, Souhrada M, Wang C, Gagnier RP, Wood CC.
    J Clin Pharmacol; 2002 Aug; 42(8):881-6. PubMed ID: 12162470
    [Abstract] [Full Text] [Related]

  • 6. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis.
    Knijff-Dutmer EA, Kalsbeek-Batenburg EM, Koerts J, van de Laar MA.
    Rheumatology (Oxford); 2002 Apr; 41(4):458-61. PubMed ID: 11961179
    [Abstract] [Full Text] [Related]

  • 7. Effects of nabumetone on prostanoid biosynthesis in humans.
    Cipollone F, Ganci A, Panara MR, Greco A, Cuccurullo F, Patrono C, Patrignani P.
    Clin Pharmacol Ther; 1995 Sep; 58(3):335-41. PubMed ID: 7554708
    [Abstract] [Full Text] [Related]

  • 8. Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use.
    Blain H, Boileau C, Lapicque F, Nédélec E, Loeuille D, Guillaume C, Gaucher A, Jeandel C, Netter P, Jouzeau JY.
    Br J Clin Pharmacol; 2002 Mar; 53(3):255-65. PubMed ID: 11874389
    [Abstract] [Full Text] [Related]

  • 9. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.
    Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL, Gertz BJ, De Schepper PJ.
    J Clin Pharmacol; 2000 Oct; 40(10):1109-20. PubMed ID: 11028250
    [Abstract] [Full Text] [Related]

  • 10. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
    Prieto A, De Barrio M, Martín E, Fernández-Bohórquez M, de Castro FJ, Ruiz FJ, Herrero T, Tornero P, Rubio M.
    J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation.
    Giuliano F, Ferraz JG, Pereira R, de Nucci G, Warner TD.
    Eur J Pharmacol; 2001 Aug 24; 426(1-2):95-103. PubMed ID: 11525777
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 24; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 13. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers.
    Van Ryn J, Kink-Eiband M, Kuritsch I, Feifel U, Hanft G, Wallenstein G, Trummlitz G, Pairet M.
    J Clin Pharmacol; 2004 Jul 24; 44(7):777-84. PubMed ID: 15199082
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K, Hatanaka K, Kawamura M, Katori M, Harada Y.
    Pharmacology; 1997 Jul 24; 55(1):44-53. PubMed ID: 9309800
    [Abstract] [Full Text] [Related]

  • 15. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
    Pairet M, van Ryn J, Schierok H, Mauz A, Trummlitz G, Engelhardt G.
    Inflamm Res; 1998 Jun 24; 47(6):270-6. PubMed ID: 9683035
    [Abstract] [Full Text] [Related]

  • 16. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa.
    Tavares IA.
    Aliment Pharmacol Ther; 2000 Jun 24; 14(6):795-9. PubMed ID: 10848664
    [Abstract] [Full Text] [Related]

  • 17. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam.
    Weber EW, Slappendel R, Durieux ME, Dirksen R, van der Heide H, Spruit M.
    Eur J Anaesthesiol; 2003 Dec 24; 20(12):963-6. PubMed ID: 14690098
    [Abstract] [Full Text] [Related]

  • 18. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
    van Haeringen NJ, van Sorge AA, Van Delft JL, Carballosa Coré-Bodelier VM.
    J Ocul Pharmacol Ther; 2000 Aug 24; 16(4):345-52. PubMed ID: 10977130
    [Abstract] [Full Text] [Related]

  • 19. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
    Ogino K, Hatanaka K, Kawamura M, Ohno T, Harada Y.
    Pharmacology; 2000 Nov 24; 61(4):244-50. PubMed ID: 11093076
    [Abstract] [Full Text] [Related]

  • 20. NSAIDs, Cox-2 inhibitors, and the gut.
    Hayllar J, Bjarnason I.
    Lancet; 1995 Dec 16; 346(8990):1629. PubMed ID: 7500770
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.